Sam Bloom at NeuRA trying neurostimulation

eWalk trial study lead, Simon Gandevia, explains the trial and the vision

Professor Simon Gandevia of NeuRA, lead scientist on the eWalk neurostimulation trial, explains how this gold standard trial is aiming to improve walking and other functions in people with incomplete spinal cord injury. This research was instigated by SpinalCure, and…
Injectable stimulator - courtesty University of Cambridge

Tiny spinal cord stimulator could improve access to treatment

A tiny inflatable spinal cord stimulator has been developed by researchers at the University of Cambridge with the aim of making spinal cord stimulation more practical and accessible. While the device was developed for people with back or leg pain,…
Embryonic Stem Cells

World-first study using adult-derived stem cells on spinal cord injury patients begins

The first clinical study using adult-derived stem cells with the aim of treating people with spinal cord injuries has begun in Japan, at Keio University. The research team, led by Prof. Masaya Makamura, an orthopedic specialist, and Prof. Hideyuki Okano,…
A research participant with spinal cord injury walks in the Ekso GT assisted by a physical therapist

Exoskeleton assisted walking improves bowel function in people with chronic SCI

In further validation of the benefits of upright posture and exercise, a team of researchers from the US has reported that the time taken for bowel care and stool form were both improved by exoskeleton-assisted walking. These results were obtained…
Injured nerves stop themselves from healing

Insights into why injured nerves in the central nervous system stop themselves from healing

Three main causes for the inability of injured nerves of the central nervous system, or CNS, to regenerate have been known to date: the insufficient activation of a regeneration program in injured nerve cells that stimulates the growth of fibers,…
Physiotherapist with trial participant

Landmark trial aims to help people with spinal cord injury walk again

Wednesday 2 June, Sydney, Australia: Australian researchers are embarking on a landmark international trial which aims to help people with spinal cord injury walk again. Led by researchers at Neuroscience Research Australia (NeuRA) and primarily funded by SpinalCure Australia and…
screen grab from video

Leukocyte fluctuations predict recovery from SCI

This video summarises the findings of research by A/Prof Marc Ruitenberg and his team, into leukocyte fluctuations in traumatic spinal cord injury. The published paper provides the first detailed description as to how the nature and level of a spinal…
Clinical trial

Mayo Clinic (USA): Clinical trial of mesenchymal stem cells for traumatic SCI

Led by Dr Allan Dietz at the Mayo Clinic, this clinical trial will investigate the safety and potential therapeutic effects of mesenchymal stem cells derived from the patients own adipose tissue (body fat). Eligible participants include those with sub-acute or…